Professor Adib Domingos Jatene, indelible mark of pioneering spirit, honesty, wisdom and accurate surgical technique, left this life on the 14^th^ of November.

It saddened the entire Brazilian nation, impoverished without his striking and distinguished presence, always dedicated to healing the heart of ill patients and Brazil\'s flaws.

It especially dismayed cardiovascular surgeons, who have him as a paradigm and exemplary teacher. He was Chairman of the Department of Cardiovascular Surgery; Founding member and President of the Brazilian Society of Cardiovascular Surgery (BSCVS); one of the founders and first Chief Editor of the Brazilian Journal of Cardiovascular Surgery (BJCVS) back in 1982, implementing the journal inception in 1986. Certainly, as Socrates, Professor Jatene is not dead! He will live on his mission of great physician, dedicated teacher, inventor, class leader, competent administrator in higher academic and government positions, and exemplary citizen.

The legacy left by the thousands of disciples who he formed, and friends who had the privilege to live with him over the 85 years of his fruitful existence is eternal, therefore, his lessons will continue to be propagated throughout the ages in a chain of ideas and dignified conduct of the great leaders of national and international opinion.

Read more about life and the role of Dr. Adib Jatene in Brazilian cardiovascular surgery from page 473.

Dr. Raul Rabelo
===============

Also, Dr. Raul Corrêa Rabelo, from Belo Horizonte, MG, left us on November 12, after 68 years. He was one of the most outstanding figures in the history of Brazilian cardiovascular surgery, leaving a great legacy and an example of dignity and perseverance to all those who had the privilege to live with him. He was an active member of the Board of the Brazilian Society of Cardiovascular Surgery in managements 1990-1992 and 1992-1994.

BJCVS in English
================

In a landmark decision, the members of the Brazilian Society of Cardiovascular Surgery (BSCVS) approved at a meeting held during the Brazilian Cardiology Congress in Brasília, that from 2015 the Brazilian Journal of Cardiovascular Surgery (BJCVS) will be published exclusively in English, the lingua franca of science in modern times.

This is an important step not only for the consolidation of our journal on the international scenario, but also an incentive so that cardiac surgeons and allied professionals who submit manuscripts to BJCVS can improve themselves in the English language. I thank colleagues and Board of BSCVS for their efforts to make this change a reality.

This new dynamic will also accelerate availability on the Scielo and other databases, giving greater visibility and enabling the latest articles can be read and certainly cited with positive impact on Impact Factor, a fact crucial to the evolution of our publication in the concert of nations. As a matter of workflow, Scielo makes available its edition in both languages together. As the Portuguese version was ready before, due to the print edition, there was a great period of time until the two versions were available.

Although on its website ([www.rbccv.org.br](http://www.rbccv.org.br)) this problem does not occur, the SciELO is responsible for distributing the files to the PubMed and this delay just makes the articles were accessible on that database only months after completion, an incompatible situation with the necessary agility in these days of instant communication.

Regarding manuscripts, for those already sent in Portuguese, following approval for publication, the author will be asked to send the English version. If not, the version will be made by the translators team of BJCVS, with the costs being borne by the authors, as already stated in Rules for Authors. So that the process can be streamlined and the publication occurs in less time, it is essential that the manuscripts are submitted in English, with quality compatible with international levels of scientific language.

We have some important points to consider: a- Essentially, all journals in our area, even in Germany, France, Italy, Japan, China, India, Turkey etc. are published in English, so that we cannot stay out of the competition, with articles in English of poor quality.

b- BJCVS is one of the few Open Access journals which does not charge the authors the high sums charged by counterparts to publish the articles, so the collaboration of colleagues to invest in a good standard of translation will guarantee the success of the BJCVS and the researchers themselves.

The Editorial Board will keep in its staff reliable translators for checking the quality of language. If necessary, the translation will be rejected and the study will not be published, while not in accordance with established standards.

We count on understanding of all, so that the future of BJCVS is of full rise for the conquest of most readers, to publicize their studies in their quotations so that we do not have the frustration we had the last evaluation at Thomson Reuters on which our Impact Factor fell by 35%.

c- We hope these measures grow back above the levels we\'ve ever had.

The Editorial Board of BJCVS is available to answer any questions by any means available.

It is not our wish harm colleagues, but offer them the opportunity to count on a disclosure body in the level of greatness of our Brazilian Society of Cardiac Surgery.

Bimonthly
=========

Another novelty is that the BJCVS will change from quarterly to bimonthly (one edition every two months), a change that aims to streamline the flow of articles.

Since today our journal has a large number of submissions, some manuscripts, as approved, have long waiting time to be published.

To minimize this problem, preventing damage to the authors and the journal itself, it was adopted, as in a large number of competitors, the online publication \"Ahead of Print\", providing the study on our site (<http://www.rbccv.org.br/publication-proofs>) already with the attribution of the DOI that allows proof of article precedence, as well as its quotation.

Even so, our interest has always been to publish as many studies as possible, as quickly as possible.

Unfortunately, space limitations and the high costs of print publishing (printing, postage) prevent this expansion occurs, maintaining the current number of issues per year. To get a faster flow, it is important for authors and reviewers comply strictly with the time limits.

Small but important
===================

The article \"Uprising: Less prestigious journals publishing greater share of high-impact papers\", by John Bohannon^\[[@r01]\]^, published in the Newsletter of Science in October, brought up a subject little discussed, but very important: less known publications have been responsible for the publication of articles of great impact.

Bohannon cites a study from Google Scholar (\"Rise of the Rest: The Growing Impact of Non-Elite Journals\"^\[[@r02]\]^), which shows that in 1995 only 27% of the citations were from articles published in journals outside the \"elite\" (the ten most cited journals). In 2013, this proportion rose to 47%! Although experts pointed to a few restrictions on the study of Google Scholar, as not differentiate the types of articles, as well as factors such as the growing number of journals and open access repositories, there is no denying that these figures show a trend change, which needs be observed.

These facts make us very hopeful. Since I took over as Editor-in-Chief of BJCVS in 2002, I have emphasized the importance of expanding the journal\'s horizons. Publishing in English and with the trend towards decentralization of the international flow of articles, we can attract more and better studies, which will give the necessary scientific visibility to our journal.

PubMed Central
==============

BJCVS overcame another step in the admission process to PubMed Central. We were approved in the technical evaluation and we are looking forward now for the analysis of documents and the banner we sent so that we can finally be accepted in this important database. There is no deadline for the publication of the results, we hope to give soon more good news for our readers.

CNPq
====

As we have done every year, we ask the CNPq the grant of Editorial Support for 2015. In 2014, after several years without the capital, we received R\$30.000,00, an amount below the journal\'s needs, but important to cover some costs. I hope we are again among the journals chosen, and that the amount may be greater.

**CME**

The following items are available for testing of Continuing Medical Education (CME) in this issue: \"*Risk factors of atheromatous aorta in cardiovascular surgery*\" (p. 487), \"*Very short cycles of postconditioning have no protective effect against reperfusion injury. Experimental study in rats*\" (p. 521), \"*Carotid endarterectomy in awake patients: safety, tolerability and results*\" (p. 574) and \"*Therapeutic options to minimize allogeneic blood transfusions and their adverse effects in cardiac surgery: A systematic review*\" (p. 606). I remember the CME, in addition to be a useful tool to test and update knowledge, worth 0.5 linear in Proof of Title of BSCVS, if the reader has answered all the questions of tests available from volumes 28.4 to 29.3.

2015
====

I conclude this editorial thanking the sponsors, who believe in the journal\'s quality, the authors, reviewers, the Editorial Board and BSCVS, which through its members and Directors has always supported us over the years. To all, Merry Christmas and a great 2015!

My warmest regards!
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